BHC:CC News and Press, Bausch Health Companies Inc.

2026-02-25 10:03:10 ET Shares of skin disease concern Oruka Therapeutics, Inc. ( ORKA ) have more than doubled since its IL-23p19 antagonist ORKA-001 demonstrated a half-life four times greater than Skyrizi in a Phase 1 study. The once or twice-yearly psoriasis candidate is undergoi...

Bausch Health's Aesthetics Business, Solta Medical, Announces the Launch of Clear + Brilliant® Touch Laser in Canada Canada NewsWire LAVAL, QC , Feb. 23, 2026 /CNW/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, and Solta M...

Bausch Health's OraPharma Celebrates 25 Years of ARESTIN® (minocycline HCl) Microspheres PR Newswire The only FDA‑approved locally applied antibiotic used with scaling and root planing (SRP) marks a quarter‑century of clinical use LAVAL, QC , Feb. 19, 2026 /...

2026-02-18 20:15:31 ET More on Bausch Health Companies Bausch Health Companies Inc. (BHC) Q4 2025 Earnings Call Transcript Bausch Health: RED-C Failure Leaves Blockbuster Xifaxan Without A Successor Bausch Health Companies Inc. (BHC) Presents at 44th Annual J.P. Morg...

2026-02-18 20:14:56 ET Bausch Health Companies Inc. (BHC) Q4 2025 Earnings Call February 18, 2026 5:00 PM EST... Read the full article on Seeking Alpha For further details see: Bausch Health Companies Inc. (BHC) Q4 2025 Earnings Call Transcript

BAUSCH HEALTH ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2025 RESULTS Canada NewsWire Fourth Quarter Consolidated Revenues of $2.80 billion, up 9% on a Reported basis and up 6% on an Organic (non-GAAP) 1   basis over the prior year period Full-Year Consolidated Revenues of ...

Allied Gold Corporation (AAUC:CA) is expected to report $0.87 for Q4 2025 Capstone Copper Corp. (CS:CA) is expected to report $0.13 for Q4 2025 Triple Flag Precious Metals Corp. (TFPM:CA) is expected to report $0.44 for Q4 2025 Nutrien Ltd. (NTR:CA) is expected to report $1.14 for Q4 ...

2026-02-17 17:35:32 ET More on Bausch Health Companies Bausch Health: RED-C Failure Leaves Blockbuster Xifaxan Without A Successor Bausch Health Companies Inc. (BHC) Presents at 44th Annual J.P. Morgan Healthcare Conference Bausch Health Companies Inc. (BHC) Presents...

Bausch Health Announces 2026 Gastrointestinal Health Scholars Program PR Newswire Bausch Health to Provide Scholarships to 10 Students Living with GI Diseases LAVAL, QC , Feb. 11, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE: BHC)(TSX: BHC) and its gastroenterology ...

2026-01-23 14:35:21 ET Bausch Health Companies Inc. ( BHC ) stock is off nearly 10% in intraday trading after reporting that its Phase 3 program evaluating "next-gen" rifaximin to delay the first episode of hepatic encephalopathy in patients with cirrhosis failed.... R...